Not recruiting
Colorectal cancer+2
Not recruitingStudy on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer
Registered drugNo placebo
Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer
Registered drugNo placebo
- Disease:Colorectal cancerAdenocarcinoma pancreas+1
- Substances:AZD0022Cetuximab
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:AZD0022



